Dr. Andrew Lee graduated cum laude and with Phi Beta Kappa honors from UCLA. He then went on to complete his medical degree at the NYU School of Medicine. After his internship in internal medicine at UC Irvine School of Medicine, he went on to complete his residency in ophthalmology at the Northwell Health Eye Institute in New York where he served as chief resident in his final year. Dr. Lee then went on to receive additional training at the Jules Stein Eye Institute at UCLA where he completed a fellowship in Cornea, External Diseases, and Refractive Surgery.
A dedicated clinician scientist, Dr. Lee has published several papers in multiple peer-reviewed medical journals regarding topics in cornea, retina, glaucoma, and pediatric ophthalmology. Notably, he was the first to report on acute angle-closure induced by daratumumab, a monoclonal antibody used to treat relapsing multiple myeloma. He finds tremendous joy and satisfaction in improving the health of patients’ eyes, and remains at the forefront of medical knowledge and surgical skills to ensure the best possible outcomes for his patients.
In his free time, he enjoys spending time with his wife and two children. Dr. Lee is a native of Irvine, and is thrilled to be back home where he can give back to the community that has given him so much.
Training and Certifications
University Of California, Los Angeles, BS, Cum Laude
New York University School Of Medicine, MD
UC Irvine School Of Medicine, Internship (Internal Medicine)
Northwell Health Eye Institute, Residency (Ophthalmology), Chief Resident
Stein Eye Institute At UCLA, Fellowship (Cornea, External Diseases, And Refractive Surgery)
American Board Of Ophthalmology, Diplomate
American Academy Of Ophthalmology, Member